Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genome-Based Classification and Therapy of Prostate Cancer.
Angeles AK, Bauer S, Ratz L, Klauck SM, Sültmann H. Angeles AK, et al. Diagnostics (Basel). 2018 Sep 2;8(3):62. doi: 10.3390/diagnostics8030062. Diagnostics (Basel). 2018. PMID: 30200539 Free PMC article. Review.
Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
Dietz S, Christopoulos P, Yuan Z, Angeles AK, Gu L, Volckmar AL, Ogrodnik SJ, Janke F, Fratte CD, Zemojtel T, Schneider MA, Kazdal D, Endris V, Meister M, Muley T, Cecchin E, Reck M, Schlesner M, Thomas M, Stenzinger A, Sültmann H. Dietz S, et al. Among authors: angeles ak. EBioMedicine. 2020 Dec;62:103103. doi: 10.1016/j.ebiom.2020.103103. Epub 2020 Nov 9. EBioMedicine. 2020. PMID: 33161228 Free PMC article.
Earlier extracranial progression and shorter survival in ALK-rearranged lung cancer with positive liquid rebiopsies.
Christopoulos P, Dietz S, Angeles AK, Rheinheimer S, Kazdal D, Volckmar AL, Janke F, Endris V, Meister M, Kriegsmann M, Zemojtel T, Reck M, Stenzinger A, Thomas M, Sültmann H. Christopoulos P, et al. Among authors: angeles ak. Transl Lung Cancer Res. 2021 May;10(5):2118-2131. doi: 10.21037/tlcr-21-32. Transl Lung Cancer Res. 2021. PMID: 34164264 Free PMC article.
Serum cytokines predict efficacy and toxicity, but are not useful for disease monitoring in lung cancer treated with PD-(L)1 inhibitors.
Schindler H, Lusky F, Daniello L, Elshiaty M, Gaissmaier L, Benesova K, Souto-Carneiro M, Angeles AK, Janke F, Eichhorn F, Kazdal D, Schneider M, Liersch S, Klemm S, Schnitzler P, Stenzinger A, Sültmann H, Thomas M, Christopoulos P. Schindler H, et al. Among authors: angeles ak. Front Oncol. 2022 Oct 31;12:1010660. doi: 10.3389/fonc.2022.1010660. eCollection 2022. Front Oncol. 2022. PMID: 36387148 Free PMC article.
13 results